[1]
|
WHO. China Globocan, 2020. https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf
|
[2]
|
WHO. Globocan, 2020. https://gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf
|
[3]
|
Liu, R., Zhang, C., Hu, Z., et al. (2011) A Five-microRNA Signature Identified from Genome-Wide Serum microRNA Expression Profiling Serves as a Fingerprint for Gastric Cancer Diagnosis. European Journal of Cancer, 47, 784-791.
https://doi.org/10.1016/j.ejca.2010.10.025
|
[4]
|
Liu, G., Jiang, C., Li, D., et al. (2014) MiRNA-34a Inhibits EGFR-Signaling-Dependent MMP7 Activation in Gastric Cancer. Tumor Biology, 35, 9801-9806. https://doi.org/10.1007/s13277-014-2273-6
|
[5]
|
Bonetti, P., Climent, M., Panebianco, F., et al. (2019) Dual Role for miR-34a in the Control of Early Progenitor Proliferation and Commitment in the Mammary Gland and in Breast Can-cer. Oncogene, 38, 360-374.
https://doi.org/10.1038/s41388-018-0445-3
|
[6]
|
Shen, Z., Zhan, G., Ye, D., et al. (2012) MicroRNA-34a Affects the Occurrence of Laryngeal Squamous Cell Carcinoma by Targeting the Antiapoptotic Gene Survivin. Medical Oncology, 29, 2473-2480.
https://doi.org/10.1007/s12032-011-0156-x
|
[7]
|
Ji, Q., Hao, X., Meng, Y., et al. (2008) Restoration of Tumor Suppressor miRNA-34 Inhibits Human p53-Mutant Gastric Cancer Tumorspheres. BMC Cancer, 8, Article No. 266. https://doi.org/10.1186/1471-2407-8-266
|
[8]
|
Kim, C.H., Kim, H.K., Rettig, R.L., et al. (2011) miRNA Signature Associated with Outcome of Gastric Cancer Patients Following Chemotherapy. BMC Medical Genomics, 4, Article No. 79. https://doi.org/10.1186/1755-8794-4-79
|
[9]
|
Bartel, D.P. (2004) MicroRNAs: Genomics, Biogenesis, Mecha-nism, and Function. Cell, 116, 281-297.
https://doi.org/10.1016/S0092-8674(04)00045-5
|
[10]
|
He, L. and Hannon, G.J. (2004) MicroRNAs: Small RNAs with a Big Role in Gene Regulation. Nature Reviews Genetics, 5, 522-531. https://doi.org/10.1038/nrg1379
|
[11]
|
Miska, E.A. (2005) How microRNAs Control Cell Division, Differentiation and Death. Current Opinion in Genetics & Development, 15, 563-568. https://doi.org/10.1016/j.gde.2005.08.005
|
[12]
|
Bartel, D.P. (2009) MicroRNAs: Target Recognition and Regulato-ry Functions. Cell, 136, 215-233.
https://doi.org/10.1016/j.cell.2009.01.002
|
[13]
|
Pasquinelli, A.E. (2012) MicroRNAs and Their Targets: Recogni-tion, Regulation and an Emerging Reciprocal Relationship. Nature Reviews Genetics, 13, 271-282. https://doi.org/10.1038/nrg3162
|
[14]
|
Zhang, L., Liao, Y. and Tang, L. (2019) MicroRNA-34 Family: A Potential Tumor Suppressor and Therapeutic Candidate in Cancer. Journal of Experimental & Clinical Cancer Research, 38, Arti-cle No. 53.
https://doi.org/10.1186/s13046-019-1059-5
|
[15]
|
Hayes, J., Peruzzi, P.P. and Lawler, S. (2014) MicroRNAs in Cancer: Biomarkers, Functions and Therapy. Trends in Molecular Medicine, 20, 460-469. https://doi.org/10.1016/j.molmed.2014.06.005
|
[16]
|
Kasinski, A.L. and Slack, F.J. (2012) miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-Induced Mouse Model of Lung Adeno-carcinoma. Cancer Research, 72, 5576-5587.
https://doi.org/10.1158/0008-5472.CAN-12-2001
|
[17]
|
Jafari, N. and Abediankenari, S. (2017) MicroRNA-34 Dysregulation in Gastric Cancer and Gastric Cancer Stem Cell. Tumor Biology, 39. https://doi.org/10.1177/1010428317701652
|
[18]
|
Xiong, S., Hu, M., Li, C., Zhou, X. and Chen, H. (2019) Role of miR-34 in Gastric Cancer: From Bench to Bedside (Review). Oncology Reports, 42, 1635-1646. https://doi.org/10.3892/or.2019.7280
|
[19]
|
Rokavec, M., Li, H., Jiang, L. and Hermeking, H. (2014) The p53/miRNA-34 Axis in Development and Disease. Journal of Molecular Cell Biology, 6, 214-230. https://doi.org/10.1093/jmcb/mju003
|
[20]
|
Salzman, D.W., Nakamura, K., Nallur, S., et al. (2016) miRNA-34 Ac-tivity Is Modulated through 5’-End Phosphorylation in Response to DNA Damage. Nature Communications, 7, Article No. 10954.
https://doi.org/10.1038/ncomms10954
|
[21]
|
Sun, H., Tian, J., Xian, W., Xie, T. and Yang, X. (2015) miRNA-34a Inhibits Proliferation and Invasion of Bladder Cancer Cells by Targeting Orphan Nuclear Receptor HNF4G. Disease Markers, 2015, Article ID: 879254.
https://doi.org/10.1155/2015/879254
|
[22]
|
Kaller, M. and Hermeking, H. (2016) Interplay between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer. Advances in Experimental Medicine and Biology, 937, 71-92.
https://doi.org/10.1007/978-3-319-42059-2_4
|
[23]
|
Wang, L., Yu, J., Xu, J., Zheng, C., Li, X. and Du, J. (2015) The Analysis of microRNA-34 Family Expression in Human Cancer Studies Comparing Cancer Tissues with Corre-sponding Pericarcinous Tissues. Gene, 554, 1-8.
https://doi.org/10.1016/j.gene.2014.10.032
|
[24]
|
Brzozowa, M., Mielańczyk, L., Michalski, M., et al. (2013) Role of Notch Signaling Pathway in Gastric Cancer Pathogenesis. Contemporary Oncology (Pozn), 17, 1-5. https://doi.org/10.5114/wo.2013.33765
|
[25]
|
Li, S., Wei, X., He, J., et al. (2021) The Comprehensive Landscape of miR-34a in Cancer Research. Cancer and Metastasis Reviews, 40, 925-948. https://doi.org/10.1007/s10555-021-09973-3
|
[26]
|
Zeng, Z., Chen, X., Zhu, D., Luo, Z. and Yang, M. (2017) Low Expression of Circulating MicroRNA-34c Is Associated with Poor Prognosis in Triple-Negative Breast Cancer. Yonsei Medical Journal, 58, 697-702.
https://doi.org/10.3349/ymj.2017.58.4.697
|
[27]
|
Yang, S., Li, Y., Gao, J., et al. (2013) MicroRNA-34 Suppresses Breast Cancer Invasion and Metastasis by Directly Targeting Fra-1. Oncogene, 32, 4294-4303. https://doi.org/10.1038/onc.2012.432
|
[28]
|
Park, E.Y., Chang, E., Lee, E.J., et al. (2014) Targeting of miR34a-NOTCH1 Axis Reduced Breast Cancer Stemness and Chemoresistance. Cancer Research, 74, 7573-7582. https://doi.org/10.1158/0008-5472.CAN-14-1140
|
[29]
|
Li, Y.L., Liu, X.M., Zhang, C.Y., et al. (2017) Mi-croRNA-34a/EGFR Axis Plays Pivotal Roles in Lung Tumorigenesis. Oncogenesis, 6, e372. https://doi.org/10.1038/oncsis.2017.50
|
[30]
|
Zhao, K., Cheng, J., Chen, B., Liu, Q., Xu, D. and Zhang, Y. (2017) Circulating microRNA-34 Family Low Expression Correlates with Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Disease, 9, 3735-3746. https://doi.org/10.21037/jtd.2017.09.01
|
[31]
|
Takaishi, S., Okumura, T., Tu, S., et al. (2009) Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44. Stem Cells, 27, 1006-1020. https://doi.org/10.1002/stem.30
|
[32]
|
Shi, L., Wang, Z., Geng, X., Zhang, Y. and Xue, Z. (2020) Exosomal miRNA-34 from Cancer-Associated Fibroblasts Inhibits Growth and Invasion of Gastric Cancer Cells in Vitro and in Vivo. Aging (Albany NY), 12, 8549-8564.
https://doi.org/10.18632/aging.103157
|
[33]
|
Zhou, Y., Huang, T., Siu, H.L., et al. (2017) IGF2BP3 Functions as a Potential Oncogene and Is a Crucial Target of miR-34a in Gastric Carcinogenesis. Molecular Cancer, 16, Article No. 77. https://doi.org/10.1186/s12943-017-0647-2
|
[34]
|
Zhang, Z., Kong, Y., Yang, W., et al. (2016) Upregulation of mi-croRNA-34a Enhances the DDP Sensitivity of Gastric Cancer Cells by Modulating Proliferation and Apoptosis via Tar-geting MET. Oncology Reports, 36, 2391-2397.
https://doi.org/10.3892/or.2016.5016
|
[35]
|
Pu, Y., Zhao, F., Wang, H. and Cai, S. (2017) miRNA-34a-5p Promotes Multi-Chemoresistance of Osteosarcoma through Down-Regulation of the DLL1 Gene. Scientific Reports, 7, Article No. 44218.
https://doi.org/10.1038/srep44218
|
[36]
|
Krause, C.J., Popp, O., Thirunarayanan, N., Dittmar, G., Lipp, M. and Müller, G. (2016) MicroRNA-34a Promotes Genomic Instability by a Broad Suppression of Genome Maintenance Mechanisms Downstream of the Oncogene KSHV-vGPCR. Oncotarget, 7, 10414-10432. https://doi.org/10.18632/oncotarget.7248
|
[37]
|
Wang, A.M., Huang, T.T., Hsu, K.W., et al. (2014) Yin Yang 1 Is a Target of microRNA-34 Family and Contributes to Gastric Carcinogenesis. Oncotarget, 5, 5002-5016. https://doi.org/10.18632/oncotarget.2073
|
[38]
|
Murata, H., Kawano, S., Tsuji, S., et al. (1999) Cyclooxygenase-2 Overexpression Enhances Lymphatic Invasion and Metastasis in Human Gastric Carcinoma. The American Journal of Gastroenterology, 94, 451-455.
https://doi.org/10.1111/j.1572-0241.1999.876_e.x
|
[39]
|
Bommer, G.T., Gerin, I., Feng, Y., et al. (2007) p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes. Current Biology, 17, 1298-1307. https://doi.org/10.1016/j.cub.2007.06.068
|
[40]
|
Zhang, D.G., Zheng, J.N. and Pei, D.S. (2014) P53/microRNA-34-Induced Metabolic Regulation: New Opportunities in Anticancer Therapy. Molecular Cancer, 13, Article No. 115. https://doi.org/10.1186/1476-4598-13-115
|
[41]
|
Yamakuchi, M. and Lowenstein, C.J. (2009) miRNA-34, SIRT1 and p53: The Feedback Loop. Cell Cycle, 8, 712-715.
https://doi.org/10.4161/cc.8.5.7753
|
[42]
|
Yamakuchi, M., Ferlito, M. and Lowenstein, C.J. (2008) miRNA-34a Re-pression of SIRT1 Regulates Apoptosis. Proceedings of the National Academy of Sciences of the United States of Amer-ica, 105, 13421-13426.
https://doi.org/10.1073/pnas.0801613105
|
[43]
|
Soutto, M., Chen, Z., Bhat, A.A., et al. (2019) Activation of STAT3 Signaling Is Mediated by TFF1 Silencing in Gastric Neoplasia. Nature Communications, 10, Article No. 3039. https://doi.org/10.1038/s41467-019-11011-4
|
[44]
|
Rokavec, M., Öner, M.G., Li, H., et al. (2014) IL-6R/STAT3/miR-34a Feedback Loop Promotes EMT-Mediated Colorectal Cancer Invasion and Metastasis. Journal of Clinical Investigation, 124, 1853-1867.
https://doi.org/10.1172/JCI73531
|
[45]
|
Shi, L., Fan, B., Chen, D., et al. (2020) Human Cytomegalovirus Protein UL136 Activates the IL-6/STAT3 Signal through miRNA-138 and miRNA-34c in Gastric Cancer Cells. International Journal of Clinical Oncology, 25, 1936-1944. https://doi.org/10.1007/s10147-020-01749-z
|
[46]
|
Chen, Q.Y., Des Marais, T. and Costa, M. (2019) Deregulation of SATB2 in Carcinogenesis with Emphasis on miRNA-Mediated Control. Carcinogenesis, 40, 393-402. https://doi.org/10.1093/carcin/bgz020
|
[47]
|
Lau, W.M., Teng, E., Chong, H.S., et al. (2014) CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells. Cancer Research, 74, 2630-2641. https://doi.org/10.1158/0008-5472.CAN-13-2309
|
[48]
|
Wu, Q., Yang, Z., Wang, F., et al. (2013) miR-NA-19b/20a/92a Regulates the Self-Renewal and Proliferation of Gastric Cancer Stem Cells. Journal of Cell Science, 126, 4220-4229. https://doi.org/10.1242/jcs.127944
|
[49]
|
赵丽丽, 赵文文, 冯青青, 赵文飞, 张雪, 井文君, 魏红梅. 沉默PD-L1表达对胃癌细胞生物学行为的影响[J]. 国际肿瘤学杂志, 2021, 48(12): 705-710. https://doi.org/10.3760/cma.j.cn371439-20210813-00140
|
[50]
|
郭雅文. PD-L1在乳腺癌患者预后中的诊断价值及miRNA-34a对其调控机制的研究[D]: [博士学位论文]. 武汉: 华中科技大学, 2017.
|
[51]
|
Cortez, M.A., Ivan, C., Valdecanas, D., et al. (2015) PDL1 Regulation by p53 via miRNA-34. Journal of the National Cancer Institute, 108, djv303. https://doi.org/10.1093/jnci/djv303
|
[52]
|
Hong, D.S., Kang, Y.K., Borad, M., et al. (2020) Phase 1 Study of MRX34, a Liposomal miRNA-34a Mimic, in Patients with Advanced Solid Tumours. British Journal of Cancer, 122, 1630-1637.
https://doi.org/10.1038/s41416-020-0802-1
|